Clinical Correlates and Heritability of Cystatin C (from the Framingham Offspring Study)

American Journal of Cardiology

Volumn 102, Issue 9, 2008, Pages 1194-1198

  Parikh, Nisha I ^a,b   Hwang, Shih Jen ^a,f   Yang, Qiong ^c   Larson, Martin G ^a   Guo, Chao Yu ^c   Robins, Sander J ^a   Sutherland, Patrice ^a   Benjamin, Emelia J ^a,d   Levy, Daniel ^a,f   Fox, Caroline S ^a,e,f  

^a FRAMINGHAM HEART STUDY   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CREATININE; CYSTATIN C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; GLOMERULUS FILTRATION RATE; HERITABILITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NEPHELOMETRY; PRIORITY JOURNAL; RISK FACTOR; SMOKING;

CARDIOVASCULAR DISEASES; CHRONIC DISEASE; CYSTATIN C; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; RISK FACTORS;

EID: 54549121545     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2008.06.039     Document Type: Article

References (27)

1. Liu J., Sukhova G.K., Sun J.S., Xu W.H., Libby P., and Shi G.P. Lysosomal cysteine proteases in atherosclerosis. Arterioscler Thromb Vasc Biol 24 (2004) 1359-1366
2. Rule A.D., Bergstralh E.J., Slezak J.M., Bergert J., and Larson T.S. Glomerular filtration rate estimated by cystatin C among different clinical presentations. Kidney Int 69 (2006) 399-405
3. Rule A.D., Larson T.S., Bergstralh E.J., Slezak J.M., Jacobsen S.J., and Cosio F.G. Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease. Ann Intern Med 141 (2004) 929-937
4. Stevens L.A., Coresh J., Greene T., and Levey A.S. Assessing kidney function-measured and estimated glomerular filtration rate. N Engl J Med 354 (2006) 2473-2483
5. Wasen E., Isoaho R., Mattila K., Vahlberg T., Kivela S.L., and Irjala K. Serum cystatin C in the aged: relationships with health status. Am J Kidney Dis 42 (2003) 36-43
6. Knight E.L., Verhave J.C., Spiegelman D., Hillege H.L., de Zeeuw D., Curhan G.C., and de Jong P.E. Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int 65 (2004) 1416-1421
7. Ognibene A., Mannucci E., Caldini A., Terreni A., Brogi M., Bardini G., Sposato I., Mosconi V., Salvadori B., Rotella C.M., and Messeri G. Cystatin C reference values and aging. Clin Biochem 39 (2006) 658-661
8. Shlipak M.G., Sarnak M.J., Katz R., Fried L.F., Seliger S.L., Newman A.B., Siscovick D.S., and Stehman-Breen C. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med 352 (2005) 2049-2060
9. Shlipak M.G., Katz R., Sarnak M.J., Fried L.F., Newman A.B., Stehman-Breen C., Seliger S.L., Kestenbaum B., Psaty B., Tracy R.P., and Siscovick D.S. Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease. Ann Intern Med 145 (2006) 237-246
10. Dawber T.R., and Kannel W.B. An approach to longitudinal studies in a community: the Framingham Study. Ann N Y Acad Sci 107 (1963) 539-556
11. Kannel W.B., Feinleib M., McNamara P.M., Garrison R.J., and Castelli W.P. An investigation of coronary heart disease in families. The Framingham offspring study. Am J Epidemiol 110 (1979) 281-290
12. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39 (2002) S1-S266
13. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., and Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130 (1999) 461-470
14. Coresh J., Astor B.C., McQuillan G., Kusek J., Greene T., Van Lente F., and Levey A.S. Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis 39 (2002) 920-929
15. Fox C.S., Larson M.G., Leip E.P., Culleton B., Wilson P.W., and Levy D. Predictors of new-onset kidney disease in a community-based population. JAMA 291 (2004) 844-850
16. Cupples L.A., and D'Agostino Sr. R.B. Some risk factors related to the annual incidence of cardiovascular disease and death using pooled repeated biennial measurements: Framingham Study, 30-year follow-up. In: Kannel W.B., Wolf P.A., and Garrison R.J. (Eds). The Framingham Heart Study: an Epidemiologic Investigation of Cardiovascular Disease (1987), NIH Publication, Washington, DC 87-203
17. SAS/STAT User's Guide, Version 8 (2000), SAS Institute Inc, Cary, NC
18. Peralta C.A., Whooley M.A., Ix J.H., and Shlipak M.G. Kidney function and systolic blood pressure new insights from cystatin C: data from the Heart and Soul Study. Am J Hypertens 19 (2006) 939-946
19. Benetos A., Waeber B., Izzo J., Mitchell G., Resnick L., Asmar R., and Safar M. Influence of age, risk factors, and cardiovascular and renal disease on arterial stiffness: clinical applications. Am J Hypertens 15 (2002) 1101-1108
20. Wang M.C., Tsai W.C., Chen J.Y., and Huang J.J. Stepwise increase in arterial stiffness corresponding with the stages of chronic kidney disease. Am J Kidney Dis 45 (2005) 494-501
21. U.S. Renal Data System, USRDS 2006 Annual Data Report: Atlas of End-Stage Renal Disease in the United States (2006), National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD
22. Fricker M., Wiesli P., Brandle M., Schwegler B., and Schmid C. Impact of thyroid dysfunction on serum cystatin C. Kidney Int 63 (2003) 1944-1947
23. Takeuchi M., Fukuda Y., Nakano I., Katano Y., and Hayakawa T. Elevation of serum cystatin C concentrations in patients with chronic liver disease. Eur J Gastroenterol Hepatol 13 (2001) 951-955
24. Muntner P., Winston J., Uribarri J., Mann D., and Fox C.S. Overweight, obesity, and elevated serum cystatin C levels in adults in the United States. Am J Med 121 (2008) 341-348
25. Kottgen A., Selvin E., Stevens L.A., Levey A.S., Van L.F., and Coresh J. Serum cystatin C in the United States: the Third National Health and Nutrition Examination Survey (NHANES III). Am J Kidney Dis 51 (2008) 385-394
26. Fliser D., and Ritz E. Serum cystatin C concentration as a marker of renal dysfunction in the elderly. Am J Kidney Dis 37 (2001) 79-83
27. Menon V., Shlipak M.G., Wang X., Coresh J., Greene T., Stevens L., Kusek J.W., Beck G.J., Collins A.J., Levey A.S., and Sarnak M.J. Cystatin C as a risk factor for outcomes in chronic kidney disease. Ann Intern Med 147 (2007) 19-27